Medtronic Achieves CoreValve Trial Revisions To Keep Pace With Edwards
This article was originally published in The Gray Sheet
Executive Summary
Enrollment in one section of Medtronic's U.S. pivotal study for its CoreValve transcatheter aortic heart valve will be easier now that FDA has granted conditional approval to modify the trial.